Clinical Trials

Advantagene (d.b.a. Candel Therapeutics) has GMCI™ based clinical cancer studies in prostate, brain, lung and pancreas, with notable clinical results to date.  The company’s experimental therapies target unmet medical needs, have strong scientific justification, short-term endpoints and favorable competitive positions.  Additionally, we are also researching the potential use of GMCI in other solid tumor indications.

DNA

Advantagene, Inc.

Address

117 Kendrick Street,

Suite 450

Needham,

Massachusetts 02494

Contact

6179165445

Follow

©2020 by Advantagene